Role of oral semaglutide therapy on incidence of cognitive impairment in a cohort of elderly diabetics with Heart failure with preserved ejection fraction

17 May 2025 (08:00 - 12:45)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Professor Angela Sciacqua

Magna Graecia University of Catanzaro, Catanzaro (Italy)

3 More presentations in this session

Presentation thumbnail

Prognostic implications of abnormal right ventricular-pulmonary artery coupling assessed by three-dimensional echocardiography in heart failure with preserved ejection fraction

Professor C. Shim (Seoul, KR)

Abstract Slides Video

Presentation thumbnail

Red cell distribution width (RDW) and outcomes in HFmrEF/HFpEF: Insights from FINEARTS-HF

Doctor J. Butt (Copenhagen, DK)

Abstract Slides Video

Presentation thumbnail

Higher prognostic impact of heart failure patients with preserved ejection fraction at younger age: insights from standardized mortality ratios

Doctor C. de Terwangne (Brussels, BE)

Abstract Slides Video

Access the full session

Session thumbnail

Personalised approaches to HFpEF: diagnostic tools, biomarkers, and prognostic insights

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025

You may be interested in

Congress Presentation

The impact of GLP-1 receptor agonists on cognitive decline in heart failure patients: a retrospective cohort study using real world data

Congress Presentation

Effects of SGLT2i on CGA and biomarkers of oxidative stress and platelet activation in elderly diabetic patients with HFpEF.

Congress Presentation

Effect of oral semaglutide on global longitudinal strain and global myocardial work efficiency in patients with HFpEF, uncontrolled type 2 diabetes mellitus and obesity.

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources